Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

ciprofloxacin-fluocinolone otic

ciprofloxacin-fluocinolone otic
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Otovel SOLUTION, OTIC 0.03%-0.025%    


Comments:

To be utilized in areas where single doses are more advantageous -- ED, procedural areas, etc.

May interchange to Ciprodex in areas or situations where Otovel use presents a logistical problem with expiration dates and drug stock management. For interchange use the commended dose of Ciprodex.


Reviewed: 25 April 2017 (Otovel), and 27 June 2017 (Otovel)


Last updated: Aug. 28, 2017







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.